Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Description | NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens (Novo Nordisk Ltd) |
BNF code | 0601012W0BBABAB |
Virtual Medicinal Product | Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices |
Name | NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens |
Abbreviated name | NovoMix 30 FlexPen 100units/ml inj 3ml pre-filled pens |
Date of name applicability | 27 Feb 2020 |
Previous name | NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pen |
Supplier | Novo Nordisk Ltd |
Current licensing authority | Medicines - MHRA/EMA |
EMA additional monitoring | ✗ |
Parallel import | ✗ |
Restrictions on availability | None |
Licensed Route | |
---|---|
Licenced route | Subcutaneous |
Actual Medicinal Product Packs | |
NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens (Novo Nordisk Ltd) 5 pre-filled disposable injection |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.